2026-11-02 08:26
Pressrelease
Mucocort reaches clinical milestone – patient enrolment completed in RAS01-M045A
Swedish life science company Mucocort AB has completed patient enrollment in the clinical study RAS01-M045A, marking an important milestone in the development of M045A, a local treatment for recurrent aphthous ulcers. The study will now advance to data analysis and scientific evaluation.
Umeå Biotech Incubator

